HomeCOYA • NASDAQ
add
Coya Therapeutics Inc
Previous close
$6.25
Day range
$6.12 - $6.44
Year range
$4.65 - $8.29
Market cap
129.31M USD
Avg Volume
178.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.56M | — |
Operating expense | 2.56M | 15.18% |
Net income | -2.12M | 47.39% |
Net profit margin | -59.36 | — |
Earnings per share | -0.13 | — |
EBITDA | -1.91M | 57.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.13M | -9.43% |
Total assets | 32.04M | -9.87% |
Total liabilities | 4.76M | 34.36% |
Total equity | 27.28M | — |
Shares outstanding | 20.92M | — |
Price to book | 3.83 | — |
Return on assets | -14.63% | — |
Return on capital | -17.24% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.12M | 47.39% |
Cash from operations | -1.13M | 79.30% |
Cash from investing | -516.00K | — |
Cash from financing | 19.14K | 133.97% |
Net change in cash | -1.63M | 70.50% |
Free cash flow | -1.69M | 63.50% |
About
Founded
2020
Headquarters
Website
Employees
8
